Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom W J Huizinga

Showing results (21-30 of 519) with videos related to

Pageof 52
Sort By:
Nature Clinical Practice. Rheumatology|August 26, 2006
Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?Tom W J Huizinga, Robert B M Landewé
Methods in Molecular Medicine|October 24, 2007
In vitro matrigel fibroblast invasion assayTanja C A Tolboom, Tom W J Huizinga
Annals of the Rheumatic Diseases|August 7, 2013
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisPaul Emery, Anthony Sebba, Tom W J Huizinga
Nature Reviews. Rheumatology|August 28, 2009
Every shared epitope allele for itself?Diane van der Woude, Tom W J Huizinga
Plos Medicine|December 21, 2005
Tweaking microtubules to treat sclerodermaJacob M van Laar, Tom W J Huizinga
Nature Clinical Practice. Rheumatology|November 7, 2007
The battle between anti-cyclic citrullinated peptide and rheumatoid factor tests--a winner at last?Diane van der Woude, Tom W J Huizinga
Rheumatology and Therapy|December 2, 2020
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for BiosimilarityTom W J Huizinga, Yoshifumi Torii, Rafael Muniz
Nature Reviews. Rheumatology|February 4, 2010
Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?Yvonne P M Goekoop-Ruiterman, Tom W J Huizinga
Annals of the Rheumatic Diseases|November 25, 2010
Prevention of autoimmune rheumatic disease: state of the art and future perspectivesLars Klareskog, Peter K Gregersen, Tom W J Huizinga
Lancet (London, England)|September 28, 2010
Rheumatoid arthritisDavid L Scott, Frederick Wolfe, Tom W J Huizinga
Pageof 52

Showing results (21-30 of 519) with videos related to

Sort By:
Pageof 52
Nature Clinical Practice. Rheumatology|August 26, 2006
Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?Tom W J Huizinga, Robert B M Landewé
Methods in Molecular Medicine|October 24, 2007
In vitro matrigel fibroblast invasion assayTanja C A Tolboom, Tom W J Huizinga
Annals of the Rheumatic Diseases|August 7, 2013
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisPaul Emery, Anthony Sebba, Tom W J Huizinga
Nature Reviews. Rheumatology|August 28, 2009
Every shared epitope allele for itself?Diane van der Woude, Tom W J Huizinga
Plos Medicine|December 21, 2005
Tweaking microtubules to treat sclerodermaJacob M van Laar, Tom W J Huizinga
Nature Clinical Practice. Rheumatology|November 7, 2007
The battle between anti-cyclic citrullinated peptide and rheumatoid factor tests--a winner at last?Diane van der Woude, Tom W J Huizinga
Rheumatology and Therapy|December 2, 2020
Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for BiosimilarityTom W J Huizinga, Yoshifumi Torii, Rafael Muniz
Nature Reviews. Rheumatology|February 4, 2010
Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?Yvonne P M Goekoop-Ruiterman, Tom W J Huizinga
Annals of the Rheumatic Diseases|November 25, 2010
Prevention of autoimmune rheumatic disease: state of the art and future perspectivesLars Klareskog, Peter K Gregersen, Tom W J Huizinga
Lancet (London, England)|September 28, 2010
Rheumatoid arthritisDavid L Scott, Frederick Wolfe, Tom W J Huizinga
Pageof 52